3-(6-methoxy-3,4-dihydroquinolin-1(2H)-yl)-1-(4-o-tolylpiperazin-1-yl)propan-1-one

ID: ALA4540163

PubChem CID: 121596739

Max Phase: Preclinical

Molecular Formula: C24H31N3O2

Molecular Weight: 393.53

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc2c(c1)CCCN2CCC(=O)N1CCN(c2ccccc2C)CC1

Standard InChI:  InChI=1S/C24H31N3O2/c1-19-6-3-4-8-22(19)26-14-16-27(17-15-26)24(28)11-13-25-12-5-7-20-18-21(29-2)9-10-23(20)25/h3-4,6,8-10,18H,5,7,11-17H2,1-2H3

Standard InChI Key:  QQGCAGRRBJCDSP-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   15.7398  -16.6203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7387  -17.4398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1536  -16.6167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4449  -16.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1564  -17.4394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4472  -17.8437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4428  -18.6556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1459  -19.0692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8551  -18.6649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8612  -17.8469    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.0320  -16.2119    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.0318  -15.3947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5705  -17.4412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2766  -17.8526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9859  -17.4469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6920  -17.8584    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.9893  -16.6297    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.6843  -18.6721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3863  -19.0835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0981  -18.6812    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.1033  -17.8631    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3969  -17.4472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8026  -19.0954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7938  -19.9108    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.4975  -20.3248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2093  -19.9217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2131  -19.1003    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5089  -18.6900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0822  -20.3126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  6  1  0
  5  3  1  0
  3  4  2  0
  4  1  1  0
  5  6  2  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
  1 11  1  0
 11 12  1  0
 10 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 16 18  1  0
 16 22  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 20 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 23  1  0
 24 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4540163

    ---

Associated Targets(Human)

C8166 (1658 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

pol Human immunodeficiency virus type 1 reverse transcriptase (18245 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 393.53Molecular Weight (Monoisotopic): 393.2416AlogP: 3.50#Rotatable Bonds: 5
Polar Surface Area: 36.02Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.36CX LogP: 4.02CX LogD: 4.01
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.78Np Likeness Score: -1.51

References

1. Huang YM, Alharbi NS, Sun B, Shantharam CS, Rakesh KP, Qin HL..  (2019)  Synthetic routes and structure-activity relationships (SAR) of anti-HIV agents: A key review.,  181  [PMID:31401538] [10.1016/j.ejmech.2019.111566]

Source